4-Aminopyridyl-Based CYP51 Inhibitors as Anti-Trypanosoma cruzi Drug Leads with Improved Pharmacokinetic Profile and in Vivo Potency

4-Aminopyridyl-Based CYP51 Inhibitors as Anti-Trypanosoma cruzi Drug Leads with Improved Pharmacokinetic Profile and in Vivo Potency

Bibliographic Details
Main Authors: Calvet, Claudia M., Vieira, Debora F., Choi, Jun Yong, Kellar, Danielle, Cameron, Michael D., Siqueira-Neto, Jair Lage, Gut, Jiri, Johnston, Jonathan B., Lin, Li, Khan, Susan, McKerrow, James H., Roush, William R., Podust, Larissa M.
Format: Online
Language:English
Published: American Chemical Society 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4148169/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4148169/

Similar Items